You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

r/r CLL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

Completed
Has Results
  • Non-Hodgkin's Lymphoma, Relapsed
  • +8 more
  • PBCAR20A
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 13, 2022

Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

Recruiting
  • Acute Myeloid Leukemia
  • CLL1 and CD38 dual-target CAR-T injection
  • Kunming, Yunnan, China
    920th Hospital of Joint LogisticsSupport Force of People's Liber
Oct 26, 2023

Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

Active, not recruiting
  • Relapsed/Refractory B Cell Malignancies
  • +3 more
  • Columbus, Ohio
  • +17 more
Aug 18, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • JWCAR029 (Relmacabtagene Autoleucel)
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Feb 17, 2022

Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United

Recruiting
  • Relapsed Chronic Lymphocytic Leukemia
  • +4 more
  • Phoenix, Arizona
  • +7 more
Apr 28, 2022

AML Trial in Hangzhou (CLL1 CAR-T)

Not yet recruiting
  • AML
  • CLL1 CAR-T
  • Hangzhou, China
    The First Affiliated Hospital, Zhejiang University
Jul 17, 2022

AML Trial in Hangzhou (CLL1+CD33 CAR-T)

Not yet recruiting
  • AML
  • CLL1+CD33 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 19, 2022

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • (no location specified)
Aug 23, 2022

Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

Recruiting
  • Chronic Lymphocytic Leukemia
    • Granada, Spain
    • +4 more
    Nov 8, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Aug 9, 2021

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • +2 more
    • New Haven, Connecticut
    • +2 more
    Aug 22, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +2 more
    • Tafasitamab
    • +2 more
    • Jacksonville, Florida
    • +16 more
    Dec 10, 2021

    Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

    Active, not recruiting
    • Multiple Myeloma
    • +4 more
    • Total Body Irradiation
    • +5 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 21, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Goshen, Indiana
    • +44 more
    Aug 3, 2022

    Tumors, Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in Victoria (Intermittent fast)

    Active, not recruiting
    • Neoplasms
    • +5 more
    • Intermittent fast
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Mar 15, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 2, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 17, 2022

    Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

    Completed
    • Chronic Lymphocytic Leukemia
      • Calgary, Alberta, Canada
      • +12 more
      Jul 7, 2022

      Richter Transformation Trial in China (R-EPOCH in Combination With Ibrutinib)

      Not yet recruiting
      • Richter Transformation
      • R-EPOCH in Combination With Ibrutinib
      • Beijing, Beijing, China
      • +10 more
      Jul 29, 2021